mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.01 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.01 |
mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
0.089 |
0.02 |